Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effect of blood flow to the heart when subjects are
treated with ticagrelor (Brilinta) or clopidogrel (antiplatelet drugs that stop the blood
from clumping together) in patients with Peripheral Artery Disease (PAD).